Andrea Ellis - Aug 17, 2021 Form 4 Insider Report for BridgeBio Pharma, Inc. (BBIO)

Role
Director
Signature
/s/ Barbara Bispham, Attorney-in-Fact
Stock symbol
BBIO
Transactions as of
Aug 17, 2021
Transactions value $
$0
Form type
4
Date filed
8/26/2021, 05:14 PM
Next filing
Mar 17, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The stock option vests and becomes exercisable in three annual installments after August 17, 2021, subject to the Reporting Person's continued service on the Issuer's Board of Directors through each such date.